| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
JG98 manufacturers
- JG-98
-
- $56.00
-
2026-07-17
- CAS:1456551-16-8
- Purity: 99.35%
- Supply Ability: 10g
- JG98
-
- $1.00
-
2019-12-26
- CAS:1456551-16-8
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 200kg
|
| Product Name: | JG98 | | Synonyms: | JG98;JG-98
(JG98);JG-98;JG 98;JG98;3-Benzyl-2-((Z)-((E)-5-(6-chloro-3-methylbenzo[d]thiazol-2(3H)-ylidene)-3-ethyl-4-oxothiazolidin-2-ylidene)methyl)thiazol-3-ium chloride;JG-98,HSP,Apoptosis,inhibit,Heat shock proteins,Inhibitor;J 98;JG98 ，S6721 | | CAS: | 1456551-16-8 | | MF: | C24H21Cl2N3OS3 | | MW: | 534.53 | | EINECS: | | | Product Categories: | | | Mol File: | 1456551-16-8.mol |  |
| storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | solubility | DMSO : 5 mg/mL (9.35 mM) | | form | Solid | | color | Yellow to orange |
| Uses | JG-98 Hsp70 Inhibitor is used for functional redundancy of HSPA1, HSPA2 and other HSPA proteins in non-small cell lung carcinoma. | | in vivo | JG-98 (3 mg/kg; i.p.; on days 0, 2, and 4) suppresses tumor growth in xenograft models bearing MCF7 and HeLa cells[2]. | Animal Model: | 6-week-old NCR mice (xenografts of MCF7 and HeLa cells)[2] | | Dosage: | 3 mg/kg | | Administration: | Intraperitoneal injection; on days 0, 2, and 4 | | Result: | Limited tumor growth, but somewhat less effectively. |
|
| | JG98 Preparation Products And Raw materials |
|